Gunnar Mattsson
Chief Executive Officer chez Åskvägen Förvaltning AB
Profil
Gunnar Mattsson is currently the President, Chief Executive Officer & Director at Advokatfirman Lindahl.
i Uppsala AB.
He is also the Chief Executive Officer & Director at Åskvägen Förvaltning AB, Chairman at GoDoc AB, Chairman at CellProtect Nordic Pharmaceuticals AB, Chairman at XNK Therapeutics AB (since 2021), Director & Partner at Advokatfirman Lindahl KB (since 1996), and a Member of The Swedish Bar Association (since 1994).
In the past, he served as Chairman at Vicore Pharma AB, Pharmacolog i Uppsala AB, and Redwood Pharma AB.
He was also a Director at PureFize Technologies AB, CareDx International AB (in 2010), iPiccolo AB, and Independent Pharmaceutica AB.
Additionally, he was a Partner at Advokatfirman Lindahl i Göteborg AB.
Mr. Mattsson graduated from the University of Uppsala.
Postes actifs de Gunnar Mattsson
| Sociétés | Poste | Début |
|---|---|---|
Advokatfirman Lindahl KB
 Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl KB operates a law firm. It specializes in commercial dispute resolution, mergers and acquisitions, intellectual property, and life sciences. The company was founded on January 1, 1990 and is headquartered in Stockholm, Sweden. | Director/Board Member | 01/01/1996 |
| GoDoc AB | Chairman | - |
Advokatfirman Lindahl i Uppsala AB
 Advokatfirman Lindahl i Uppsala AB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl i Uppsala AB is a law firm based in Uppsala, Sweden. The CEO of the Swedish company is Gunnar Mattsson. | Chief Executive Officer | - |
| The Swedish Bar Association | Corporate Officer/Principal | 01/01/1994 |
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The private company was founded in 2012 and the CEO is Johan Liwing. | Chairman | - |
XNK Therapeutics AB
 XNK Therapeutics AB Pharmaceuticals: MajorHealth Technology XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden. | Chairman | 04/10/2021 |
| Åskvägen Förvaltning AB | Chief Executive Officer | - |
Anciens postes connus de Gunnar Mattsson
| Sociétés | Poste | Fin |
|---|---|---|
| REDWOOD PHARMA AB | Chairman | - |
Advokatfirman Lindahl i Göteborg AB
 Advokatfirman Lindahl i Göteborg AB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl i Göteborg AB is a law firm based in Gothenburg, Sweden. The Swedish company was founded in 2005 and operates as a law firm. | Corporate Officer/Principal | - |
| ░░░░░░░░░░░ ░ ░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Gunnar Mattsson
| University of Uppsala | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHARMACOLOG I UPPSALA AB | Electronic Technology |
| REDWOOD PHARMA AB | Health Technology |
| Entreprise privées | 13 |
|---|---|
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl KB operates a law firm. It specializes in commercial dispute resolution, mergers and acquisitions, intellectual property, and life sciences. The company was founded on January 1, 1990 and is headquartered in Stockholm, Sweden. | Commercial Services |
PureFize Technologies AB
 PureFize Technologies AB SemiconductorsElectronic Technology PureFize Technologies AB is a green technology company, which engages in developing and manufacturing UV light sources and lamp systems that are used to disinfect water, air, food, and surfaces. The company was founded in 1996 and is headquartered in Uppsala, Sweden. | Electronic Technology |
CareDx International AB
 CareDx International AB BiotechnologyHealth Technology CareDx International AB engages in the development, manufacture, and sale of products for transplantation of blood stem cells and organs. It offers tissue typing products and products for antibody detection. The company was founded by Ingemar Lagerlöf in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
iPiccolo AB
 iPiccolo AB Catalog/Specialty DistributionRetail Trade iPiccolo AB provides electronic commerce. It trades computer products, office supplies, batteries, vacuum cleaners, food supplements, and accessories. The company was founded by Lennart Nyberg and Hans Nilsson in 2000 and is headquartered in Uppsala, Sweden. | Retail Trade |
Independent Pharmaceutica AB
 Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Distribution Services |
| The Swedish Bar Association | |
Advokatfirman Lindahl i Göteborg AB
Advokatfirman Lindahl i Göteborg AB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl i Göteborg AB is a law firm based in Gothenburg, Sweden. The Swedish company was founded in 2005 and operates as a law firm. | Commercial Services |
| GoDoc AB | |
Advokatfirman Lindahl i Uppsala AB
Advokatfirman Lindahl i Uppsala AB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl i Uppsala AB is a law firm based in Uppsala, Sweden. The CEO of the Swedish company is Gunnar Mattsson. | Commercial Services |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The private company was founded in 2012 and the CEO is Johan Liwing. | Health Technology |
XNK Therapeutics AB
XNK Therapeutics AB Pharmaceuticals: MajorHealth Technology XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden. | Health Technology |
| Åskvägen Förvaltning AB |
